Why Augmedics isn’t rushing to IPO after landing an $83 million Series D


CEO Kevin Hykes spoke with Chicago Inno about what stood out to him about fundraising in 2023 and what's next for the company amid stunted exit activity.

Previous Twin Peaks sets date to open Jax location
Next After Florida Blue wins state contract, other insurers fight back